Global Postmenopausal Osteoporosis Market Size

Postmenopausal Osteoporosis Market Analysis

The postmenopausal osteoporosis market is projected to register a CAGR of 3.9% during the forecast period of 2022-2027.

The outbreak of Covid-19 has significantly impacted the healthcare industry, including relative negligence of chronic diseases such as osteoporosis. A survey conducted by the National Osteoporosis Foundation and International Osteoporosis Foundation concluded that the major impact includes delays in scanning for diagnosis, interruptions in the supply of drugs and raw material, an increase in telemedicine consultations, and a decrease in parenteral medicine delivery. Further, according to a research study published in March 2021, titled 'Effects of COVID-19 Lockdown on Adherence to Individual Home- or Gym-Based Exercise Training among Women with Postmenopausal Osteoporosis', being at home can result in decreased physical activity and sedentary behavior, the COVID-19 epidemic and its constraints may have interfered with the study participants' schedules and motivation, and the reduction or lack of social bonds that are usually essential to encourage the elderly to exercise may have reduced. Hence, COVID-19 is expected to have a significant impact on the postmenopausal osteoporosis market, however, with the decreasing COVID-19 cases and large-scale vaccination programs, the studied market is expected to regain its full potential over the forecast period.

The aging population and lifestyle changes are the key factors responsible for the growth of the postmenopausal osteoporosis market as the older population is more prone to osteoporosis and thus increase in their population is expected to be a significant growth factor. For instance, according to the World Health Organization's October 2021 report, the population of people of age 60 years and more is expected to increase from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050. Hence, the market is projected to grow during the forecast period with an increase in demand for therapy of postmenopausal osteoporosis in the older population.

Additionally, lifestyle changes such as lack of exercise, high consumption of alcohol or smoking, prolonged work duration, and unhealthy eating habits also impact the menopausal period and lead to osteoporosis in many women worldwide. Age, smoking, alcohol, and consumption of medications used to treat various diseases such as gonadotropins, excess consumption of thyroid hormone, and cytotoxic agents are some of the risk factors for causing low bone density and thereby developing osteoporosis after menopause in women. According to data published by the International Menopause Society (IMS), in 2021, more than 200 million women are estimated to suffer from osteoporosis, and 1 in 3 women aged more than 50 is expected to experience osteoporosis fracture. Therefore, due to the aforementioned factors, the studied market is expected to grow over the forecast period. However, low awareness about postmenopausal osteoporosis is expected to restrain the growth of the studied market during the forecast period.